This study is testing a blood test called TheraSure CNI-Monitor in 170 people with advanced lung cancer (NSCLC) who are receiving immunotherapy. The test looks for tiny bits of tumor DNA in the blood to see if the cancer is responding to treatment or getting worse. The goal is to…
Sponsor: Karsten Gavenis • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC